{4-[5-(3-chloro-phenoxy)-oxazolo[5,4 d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid for use in the prevention or treatment of acute kidney injury
- Application ID: EP13306417
- Status: █ APPLICATION DEEMED TO BE WITHDRAWN
Applicant
Technology Company
Attorney
Specialization
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Sanofi is specialized in A61. Sanofi is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
Timeline
- 22.04.2015 - Publication A1 (EP2862574)